We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





Blood-Drawing Robot Featured at Arab Health 2024

By HospiMedica International staff writers
Posted on 30 Jan 2024
Print article

Emirates Health Services (EHS, Dubai, UAE) is participating in Arab Health 2024 where it is unveiling a blood-drawing robot introduced in its healthcare facilities. This makes EHS the first in the region to utilize such a robot.

EHS is participating as a strategic partner for healthcare services in Arab Health 2024 in four main areas. Under the theme "Innovating for Your Health... Excelling with You," EHS is showcasing 27 diverse healthcare projects, including 15 projects being presented for the first time regionally on its platform. The technology used in HEIVA, the blood-drawing robot from BhealthCare (Saint-Herblain, France), is the first of its kind regionally. It utilizes artificial intelligence (AI) and infrared imaging, ensuring high-quality service. Studies indicate that, can save 80% of the time required by medical staff and reduce patient waiting time by 50% for blood-drawing services. According to EHS, the innovative device holds 56 patents in five different areas, with three more patents to be submitted for accreditation soon. These fields cover all internal systems and technologies used. Furthermore, the new patents will soon extend to include the UAE in the near future.

H.E. Dr. Yousif Mohammed Alserkal, Director-General of EHS, emphasized that modern technology and AI have revolutionized the healthcare sector. They have become a fundamental pillar in improving the quality of medical services and enhancing comprehensive healthcare. These technologies aim to enhance the patient experience, achieve higher efficiency in healthcare delivery, provide accurate and rapid diagnoses, improve medical record management, enable effective communication among medical teams, and ultimately facilitate more accurate medical decision-making. H.E. added that EHS is keen on enhancing its leadership in the use of medical robots, given the vital role these robots play in enhancing the effectiveness and sustainability of medical services, and efficiently carrying out tasks. This allows medical teams to focus on value-added tasks. He highlighted that the blood drawing robot will contribute to elevating the quality of this service by enhancing precision and speed and minimizing risks. Additionally, he confirmed that EHS is actively involved in research studies related to the use of this robot.

H.E. Dr. Abdalla Alnaqbi, Acting Executive Director of the Clinical Support Services Sector at EHS, highlighted that technology is not just a means of progress but a vital partner that contributes to improving people's lives and delivering effective healthcare services. He noted that the introduction of the blood-drawing robot into EHS's facilities is part of their commitment to fully utilize this technology to enhance healthcare services, and ensure the provision of sustainable and high-quality healthcare for everyone. He also pointed out that EHS is proactive in enhancing its medical and therapeutic services by equipping its hospitals with surgical robots.

Related Links:
EHS 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Parenteral Nutrition Solution
Olimel Portfolio
New
Bariatric Flip Seat Scale
Detecto 6868

Print article

Channels

Critical Care

view channel
Image: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants (Photo courtesy of 123RF)

Basal Cell Carcinoma Treatment Reduces Tumor Size, Improves Surgical Removal

Basal cell carcinomas, the most prevalent type of skin cancer, often appear in areas exposed to the sun, such as the face. Locally advanced tumors, in particular, present challenges for surgical treatment.... Read more

Surgical Techniques

view channel
Image: LumiSystem is the combination of two FDA approved products: LUMISIGHT (pegulicianine) and Lumicell Direct Visualization System (Photo courtesy of Lumicell)

Pioneering Technology Enables Real-Time Detection of Residual Breast Cancer During Lumpectomy

Breast cancer is the most frequently diagnosed cancer in women, with lumpectomies being the most common treatment approach. About 65% of women diagnosed with breast cancer undergo a lumpectomy, also referred... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
ARAB HEALTH 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.